Business
Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales.
About this update from U.s. Stem Cell, Inc.
[{"type":"text","content":"\n\n\n\nMarket Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMarket Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales\n2016 to 2017 Numbers Show Consistent Growth\nPR Newswire\nSUNRISE, Fla., April 24, 2018\n\n\n\nSUNRISE, Fla., April 24, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced sales figures for 2016 and 2017 for both its AdipoCell TM proprietary stem cell kit and the stem cell banking businesses -- both of which demonstrate steady growth.\n\n\n \n \n\n \nFrom 2016 to 2017, average monthly sales of AdipoCellTM increased 11%, from 209 a month to 234 a month. Sales revenue figures for first quarter 2018 are expected to be released sometime in mid May.\n\n\"The steady and significant growth in our AdipoCellTM kits is an indicator that Americans are starting to hear about the benefits of stem cell therapy, and are taking steps to augment their health or preserve their stem cells now, so that they have reserves later in life when health or aging issues may come into play,\" said Mike Tomas, President and CEO of U.S. Stem Cell, Inc.  \"Our increase in sales reflect the growing interest in this emerging therapy.  Our operations are prepared for continued growth in 2018 in order to offer this holistic therapy to as many people as possible.\"\n\nEarlier this month, USRM opened its third partially owned standalone clinic in the United States, the newest location at The Villages in North Central Florida (the two existing clinics are in Sunrise and West Palm Beach, Florida). The Company continues to identify opportunities for clinical operations worldwide.\n\n\"Our increase in patients is providing us with an opportunity to serve the needs of more and more patients who had given up hope of improving their quality of life before considering stem cell therapy as a viable option,\" said Dr. Kristin Comella, USRM's Chief Science O...